AAM
STJ

Alpine Associates Management’s St Jude Medical STJ Stock Holding History

Alpine Associates Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,717,400
Closed -$138M – 81
2016
Q4 		$138M Sell
1,717,400
-386,200
-18% -$30.7M 3.6% 9
2016
Q3 		$168M Buy
2,103,600
+388,600
+23% +$31.4M 6.16% 1
2016
Q2 		$134M Buy
+1,715,000
New +$122M 4.77% 1

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Alpine Associates Management's STJ Position: Q1 2017 in Review

Alpine Associates Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 1,717,400 shares — an estimated $138M sold.

Alpine Associates Management first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $168M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Alpine Associates Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Alpine Associates Management sold 1,717,400 St Jude Medical shares in Q1 2017, an estimated $138M.
  • Alpine Associates Management first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
  • Alpine Associates Management's St Jude Medical position peaked at $168M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Alpine Associates Management's 13F filing for Q1 2017, filed 12 May 2017.